Assembly Biosciences Q4 EPS $(1.74) Beats $(2.88) Estimate, Sales $7.16M

benzinga_article
2024.03.29 03:36

Assembly Biosciences (纳斯达克股票代码：ASMB) 报告每股亏损 1.74 美元，超过分析师共识预期的 2.88 美元，增幅达到 39.58%。与去年同期每股亏损 5.52 美元相比，亏损增长了 68.48%。该公司本季度销售额为 716 万美元

Assembly Biosciences（纳斯达克股票代码：ASMB）报告每股亏损 1.74 美元，超过分析师预期的 2.88 美元，增幅达 39.58%。与去年同期每股亏损 5.52 美元相比，亏损增长了 68.48%。该公司本季度销售额为 716 万美元

Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.